TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses-Reference-Cited by-同舟云学术

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

Published:2008-03 Issue:13 Volume:26 Page:1626-1637
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Schlosser Eva,Mueller Marc,Fischer Stefan,Basta Sameh,Busch Dirk H.,Gander Bruno,Groettrup Marcus

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference54 articles.

1. Tolerogenic dendritic cells;Steinman;Annu Rev Immunol,2003

2. TLR signaling;Akira;Curr Top Microbiol Immunol,2006

3. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in cytotoxic assay;Bevan;J Exp Med,1976

4. The cross-priming pathway: a portrait of an intricate immune system;Basta;Scand J Immunol,2007

5. Cross-presentation: underlying mechanisms and role in immune surveillance;Rock;Immunol Rev,2005

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan non-particulate vaccine delivery systems;Journal of Pharmacy & Pharmaceutical Sciences;2024-07-24

2. EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s;Journal of Leukocyte Biology;2024-07-23

3. mRNA vaccine designs for optimal adjuvanticity and delivery;RNA Biology;2024-03-26

4. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy;Drug Delivery and Translational Research;2024-03-01

5. Development of therapeutic cancer vaccines using nanomicellar preparations;Oncology and Translational Medicine;2023-12